Nonmelanoma Skin Cancer and the Risk of Second Primary Cancers: a Systematic Review
Open Access
- 1 July 2010
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (7), 1686-1695
- https://doi.org/10.1158/1055-9965.epi-10-0243
Abstract
Background: Based on empirical evidence, a personal history of nonmelanoma skin cancer (NMSC) has been hypothesized to be a risk factor for other cancers. Others hypothesize that NMSC may be a marker of high cutaneous vitamin D synthesis and therefore inversely associated with risk of other malignancies. To reconcile these divergent views, we carried out a systematic review to determine the association between NMSC and subsequent risk of other cancers. Methods: Bibliographic databases were searched through March 2009. Studies were included if sufficient information was presented to estimate the risk of developing other cancers following NMSC. Studies were reviewed and data were abstracted independently in duplicate with disagreements resolved by consensus. Results: Of the 21 included studies, 15 reported the association between NMSC and risk of all other cancers combined. NMSC was significantly associated with increased risk of another malignancy among cohort studies based on cancer registries [summary random-effects relative risk (SRR), 1.12; 95% confidence interval (CI), 1.07-1.17; n = 12 studies) and those with individual-level data (SRR, 1.49; 95% CI, 1.12-1.98; n = 3). In stratified analyses of registry studies, this association held true for both squamous (SRR, 1.17; 95% CI, 1.12-1.23; n = 7) and basal cell carcinoma (SRR, 1.09; 95% CI, 1.01-1.17; n = 7), and both men (SRR, 1.14; 95% CI, 1.09-1.20; n = 12) and women (SRR, 1.10; 95% CI, 1.04-1.15; n = 12). Conclusions: Strong, consistent evidence indicates that a personal history of NMSC is associated with increased risk of developing other malignancies. Impact: For unknown reasons, NMSC may be a risk factor for other cancers. Cancer Epidemiol Biomarkers Prev; 19(7); 1686–95. ©2010 AACR.Keywords
This publication has 51 references indexed in Scilit:
- Second primary cancers in patients with skin cancer: a population-based study in Northern IrelandBritish Journal of Cancer, 2009
- Nonmelanoma Skin Cancer and Risk for Subsequent MalignancyJNCI Journal of the National Cancer Institute, 2008
- A systematic comparison of software dedicated to meta-analysis of causal studiesBMC Medical Research Methodology, 2007
- Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: Vitamin D as a possible explanationEuropean Journal of Cancer, 2007
- Skin cancer and non-Hodgkin's lymphoma as second malignancies: markers of impaired immune function?European Journal Of Cancer, 2003
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002
- Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries.BMJ, 1993
- Occurrence of other malignancies in 1973 patients with basal cell carcinomaJournal of the American Academy of Dermatology, 1991
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986